In a groundbreaking development that could transform the therapeutic landscape of one of the most aggressive breast cancer subtypes, researchers have unveiled a novel triple-fusion vaccine that effectively targets survivin, a protein notoriously implicated in cancer cell survival and proliferation. The study, recently published in Medical Oncology, reports remarkable success in inhibiting tumor growth in […]